Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$277.25 - $366.29 $1.39 Million - $1.83 Million
5,000 Added 74.63%
11,700 $3.88 Million
Q4 2021

Feb 15, 2022

SELL
$300.63 - $371.35 $2.65 Million - $3.27 Million
-8,800 Reduced 56.77%
6,700 $2.41 Million
Q3 2021

Nov 16, 2021

SELL
$310.19 - $376.2 $2.26 Million - $2.75 Million
-7,300 Reduced 32.02%
15,500 $5.05 Million
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $3.21 Million - $4.28 Million
12,200 Added 115.09%
22,800 $7.12 Million
Q1 2021

May 18, 2021

SELL
$285.92 - $355.13 $8.81 Million - $10.9 Million
-30,800 Reduced 74.4%
10,600 $3.38 Million
Q4 2020

Feb 17, 2021

SELL
$251.88 - $324.2 $4 Million - $5.15 Million
-15,900 Reduced 27.75%
41,400 $13.4 Million
Q3 2020

Nov 17, 2020

BUY
$255.22 - $317.0 $5.92 Million - $7.35 Million
23,200 Added 68.04%
57,300 $15.9 Million
Q2 2020

Aug 17, 2020

BUY
$141.4 - $257.09 $3.17 Million - $5.76 Million
22,400 Added 191.45%
34,100 $8.24 Million
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $3.13 Million - $4.7 Million
-24,000 Reduced 67.23%
11,700 $1.7 Million
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $4.33 Million - $6.08 Million
27,200 Added 320.0%
35,700 $6.09 Million
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $1.09 Million - $1.73 Million
-6,200 Reduced 42.18%
8,500 $1.51 Million
Q2 2019

Aug 15, 2019

SELL
$250.96 - $284.94 $2.61 Million - $2.96 Million
-10,400 Reduced 41.43%
14,700 $3.83 Million
Q1 2019

May 16, 2019

SELL
$276.39 - $362.25 $1.49 Million - $1.96 Million
-5,400 Reduced 17.7%
25,100 $7.17 Million
Q4 2018

Feb 15, 2019

BUY
$281.08 - $444.25 $7.36 Million - $11.6 Million
26,200 Added 609.3%
30,500 $9.91 Million
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $319,077 - $404,775
-900 Reduced 17.31%
4,300 $1.93 Million
Q2 2018

Aug 15, 2018

BUY
$278.07 - $446.21 $1.45 Million - $2.32 Million
5,200 New
5,200 $2.13 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.